肿瘤微环境响应型多柔比星前药的研究进展

doi:10.20223/j.cnki.1000-8535.2025.09.005

摘要/Abstract

摘要： 与正常组织细胞微环境相比,肿瘤微环境具有一定的异质性,包括偏酸性、氧化还原状态失衡、存在高浓度活性氧以及酶过量表达等。根据以上肿瘤微环境特点,可设计出一系列通过各种特殊微环境响应型连接臂相连的小分子或聚合物前药纳米粒。其中,多柔比星阿霉素作为一类最常见的广谱抗肿瘤药物在治疗肿瘤的过程中发挥重要作用。文章探讨了在肿瘤微环境特异性的生理状态下针对不同微环境所设计的多柔比星前药及其释放特性等,归纳总结了肿瘤微环境响应型多柔比星前药的研究进展。

关键词: 肿瘤微环境, 多柔比星前药, 肿瘤治疗, 谷胱甘肽, 活性氧

Abstract: Compared with normal tissue cell microenvironment,there is some differences in tumor microenvironment,such as partial acidity,imbalance of redox state,high concentration of reactive oxygen species and cathepsin. According to the above characteristics of tumor microenvironment,a series of small molecule or polymer prodrug nanoparticles connected by various special microenvironment responsive structures can be designed. Doxorubicin,as one of the most common broad-spectrum antitumor drugs,plays an important role in the treatment of tumors. This review discusses the doxorubicin prodrug designed for different tumor microenvironments under the physiological state of tumor microenvironment specificity and their release characteristics,and summarizes the research progress of tumor microenvironment-responsive doxorubicin prodrug.

Key words: tumor microenvironment, doxorubicin prodrug, tumor therapy, glutathione, reactive oxygen species

王悦, 马文静, 侯金松, 吴豪. 肿瘤微环境响应型多柔比星前药的研究进展[J]. 广州医药, 2025, 56(9): 1189-1200.

WANG Yue, MA Wenjing, HOU Jinsong, WU Hao. Research progress of doxorubicin prodrug based on tumor microenvironment response[J]. Guangzhou Medical Journal, 2025, 56(9): 1189-1200.

参考文献

[1] CHEN X,CUBILLOS-RUIZ J R.Endoplasmic reticulum stress signals in the tumour and its microenvironment[J].Nat Rev Cancer,2021,21(2):71-88.
[2] LI C,PENET M F,WINNARD P Jr,et al.Image-guided enzyme/prodrug cancer therapy[J].Clin Cancer Res,2008,14(2):515-522.
[3] 张赟,王小凡.肿瘤微环境调控癌症发生发展的研究概述[J].中国科学:生命科学,2022,52(9):1377-1390.
[4] LI X,DIAO W,XUE H,et al.Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma[J].Cancer Lett,2020(489):163-173.
[5] ZHENG K,LI R,ZHOU X,et al.Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo[J].Int J Nanomedicine,2015(10):5327-5342.
[6] ALTORKI N K,MARKOWITZ G J,GAO D C,et al.The lung microenvironment:An important regulator of tumour growth and metastasis[J].Nat Rev Cancer,2019,19(1):9-31.
[7] DONG S X,SUN Y,LIU J,et al.Multifunctional polymeric prodrug with simultaneous conjugating camptothecin and doxorubicin for pH/reduction dual-responsive drug delivery[J].ACS Appl Mater Interfaces,2019,11(9):8740-8748.
[8] XIONG S J,WANG Z,LIU J,et al.A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy[J].Colloids Surf B Biointerfaces,2019(173):346-355.
[9] KALVA N,UTHAMAN S,AUGUSTINE R,et al.Photo- and pH-responsive polycarbonate block copolymer prodrug nanomicelles for controlled release of doxorubicin[J].Macromol Biosci,2020,20(8):e2000118.
[10] MA B,ZHANG W,WANG Y,et al.pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy[J].Acta Biomater,2018(70):186-196.
[11] ZHAO D P,LIU N,SHI K M,et al.Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug[J].Colloids Surf B Biointerfaces,2015(135):682-688.
[12] ZHANG L X,HUANG J X,BURATTO D,et al.A pH-responsive nanoparticle delivery system containing dihydralazine and doxorubicin-based prodrug for enhancing antitumor efficacy[J].Aggregate,2024,5(1):e434.
[13] YAO D F,WANG Y S,BIAN K X,et al.A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer[J].Biomaterials,2023(292):121920.
[14] ZHOU N,ZHANG N,ZHI Z,et al.One-pot synthesis of acid-degradable polyphosphazene prodrugs for efficient tumor chemotherapy[J].J Mater Chem B,2020,8(46):10540-10548.
[15] ZHANG X,ZHANG T,MA X,et al.The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy[J].Asian J Pharm Sci,2020,15(5):605-616.
[16] LIAO J H,PENG H S,LIU C,et al.Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy[J].Mater Sci Eng C Mater Biol Appl,2021(118):111527.
[17] HU H,STEINMETZ N F.Doxorubicin-loaded physalis mottle virus particles function as a pH-responsive prodrug enabling cancer therapy[J].Biotechnol J,2020,15(12):e2000077.
[18] LAGES E B,FERNANDES R S,ANDRADE M M S,et al.pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers:An effective strategy to improve pharmacokinetics and reduce toxic effects[J].Biomedecine Pharmacother,2021(144):112373.
[19] LI J G,LI X M,PEI M L,et al.Acid-labile anhydride-linked doxorubicin-doxorubicin dimer nanoparticles as drug self-delivery system with minimized premature drug leakage and enhanced anti-tumor efficacy[J].Colloids Surf B Biointerfaces,2020(192):111064.
[20] MA Y,FAN X,LI L.pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel[J].Carbohydr Polym,2016(137):19-29.
[21] CALDERÓN-GARCIDUEÑAS L,REYNOSO-ROBLES R,GONZÁLEZ-MACIEL A.Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles:The culprit of Alzheimer and Parkinson’s diseases[J].Environ Res,2019(176):108574.
[22] BUSH A I.The metallobiology of Alzheimer’s disease[J].Trends Neurosci,2003,26(4):207-214.
[23] WANG M L,ZHAI Y L,YE H,et al.High co-loading capacity and stimuli-responsive release based on cascade reaction of self-destructive polymer for improved chemo-photodynamic therapy[J].ACS Nano,2019,13(6):7010-7023.
[24] PAN Q Q,DENG X,GAO W X,et al.ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy[J].Colloids Surf B Biointerfaces,2020(194):111223.
[25] XU C D,XU L,HAN R L,et al.Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy[J].Colloids Surf B Biointerfaces,2021(201):111632.
[26] KIM Y,UTHAMAN S,PILLARISETTI S,et al.Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy[J].Acta Biomater,2020(108):273-284.
[27] ZUO W B,CHEN D Y,FAN Z X,et al.Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy[J].Acta Biomater,2020(111):327-340.
[28] TONG F,YE Y C,CHEN B,et al.Bone-targeting prodrug mesoporous silica-based nanoreactor with reactive oxygen species burst for enhanced chemotherapy[J].ACS Appl Mater Interfaces,2020,12(31):34630-34642.
[29] JIN F,QI J,LIU D,et al.Cancer-cell-biomimetic upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer[J].J Control Release,2021(337):90-104.
[30] LI Q Y,HOU W,LI M X,et al.Ultrasound combined with core cross-linked nanosystem for enhancing penetration of doxorubicin prodrug/beta-lapachone into tumors[J].Int J Nanomedicine,2020(15):4825-4845.
[31] SMEYNE M,SMEYNE R J.Glutathione metabolism and Parkinson’s disease[J].Free Radic Biol Med,2013(62):13-25.
[32] VANPOUILLE C,JEUNE N L,KRYZA D,et al.Influence of multidrug resistance on(18)F-FCH cellular uptake in a glioblastoma model[J].Eur J Nucl Med Mol Imaging,2009,36(8):1256-1264.
[33] CHENG Y,JI Y H,TONG J W.Triple stimuli-responsive supramolecular nanoassembly with mitochondrial targetability for chemophotothermal therapy[J].J Control Release,2020(327):35-49.
[34] YANG Y X,SUN B J,ZUO S Y,et al.Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading,high self-assembly stability,and high tumor selectivity[J].Sci Adv,2020,6(45):eabc1725.
[35] 宫宇,周春娜,许琛.还原响应型阿霉素前药胶束的制备及其抑制肺癌A549和乳腺癌MCF-7细胞增殖研究[J].中国新药杂志,2018,27(23):2825-2832.
[36] MA N X,SONG A X,LI Z H,et al.Redox-sensitive prodrug molecules meet graphene oxide:An efficient graphene oxide-based nanovehicle toward cancer therapy[J].ACS Biomater Sci Eng,2019,5(3):1384-1391.
[37] HUANG C Z,WU J L,JIANG W,et al.Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy[J].Mater Sci Eng C Mater Biol Appl,2018(89):15-24.
[38] SONG Q,WANG X,WANG Y Q,et al.Reduction responsive self-assembled nanoparticles based on disulfide-linked drug-drug conjugate with high drug loading and antitumor efficacy[J].Mol Pharm,2016,13(1):190-201.
[39] SANTRA S,KAITTANIS C,SANTIESTEBAN O J,et al.Cell-specific,activatable,and theranostic prodrug for dual-targeted cancer imaging and therapy[J].J Am Chem Soc,2011,133(41):16680-16688.
[40] MA X D,ÖZLISELI E,ZHANG Y Z,et al.Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy[J].Biomater Sci,2019,7(2):634-644.
[41] 陈瑶,张洪源,刘雨婷,等.肿瘤氧化还原微环境智能响应型前药纳米组装体的研究进展[J].药学进展,2021,45(5):337-348.
[42] YANG Y X,SUN B J,ZUO S Y,et al.Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading,high self-assembly stability,and high tumor selectivity[J].Sci Adv,2020,6(45):eabc1725.
[43] HE F,CAO L,ZHANG X J,et al.The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system[J].Acta Pharm Sin,2015,50(2):141-147.
[44] 王相宜,张锦,李燕,等.肿瘤代谢调控与肿瘤免疫治疗以及代谢分析方法研究进展[J].药学学报,2020,55(9):2080-2091.
[45] LIU Y,CORRALES-GUERRERO S,KUO J C,et al.Improved targeting and safety of doxorubicin through a novel albumin binding prodrug approach[J].ACS Omega,2024,9(1):977-987.
[46] 雷帅权. 对肿瘤微环境响应的抗癌纳米药物的研究[D].天津:天津工业大学,2019.
[47] 杨雨琦,巩飞,柏上,等.肿瘤微环境响应型纳米诊疗制剂的研究进展[J].药学学报,2021,56(2):465-475.
[48] ZHU Q,FAN Z,ZUO W,et al.Self-distinguishing and stimulus-responsive carrier-free theranostic nanoagents for imaging-guided chemo-photothermal therapy in small-cell lung cancer[J].ACS Appl Mater Interfaces,2020,12(46):51314-51328.
[49] YU L,ZHANG M,HE J,et al.A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy[J].Acta Biomater,2024(179):272-283.
[50] LIAO J H,PENG H S,WEI X,et al.A bio-responsive 6-mercaptopurine/doxorubicin based “Click Chemistry” polymeric prodrug for cancer therapy[J].Mater Sci Eng C Mater Biol Appl,2020(108):110461.
[51] JIN Q Y,ZHOU X H,NIU X M,et al.Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice[J].Colloids Surf B Biointerfaces,2024(241):113992.
[52] HU Y R,LIU P.Diselenide-bridged doxorubicin dimeric prodrug:synthesis and redox-triggered drug release[J].Molecules,2024,29(8):1709.
[53] WANG J,ZHANG H X,LV J Z,et al.A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors[J].Acta Biomater,2023(164):522-537.
[54] DING Y,WANG C W,MA Y X,et al.pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy[J].Acta Biomaterialia,2022(143):381-391.
[55] WANG L L,HE S S,LIU R,et al.A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment[J].Acta Pharm Sin B,2024,14(5):2263-2280.
[56] XI L,WANG J,WANG Y,et al.Dual-targeting polymeric nanocarriers to deliver ROS-responsive prodrugs and combat multidrug resistance of cancer cells[J].Macromol Biosci,2021,21(9):e2100091.
[57] REN Q,LIANG Z G,JIANG X,et al.Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy[J].Int J Biol Macromol,2019(130):845-852.
[58] LI Y,NIU Y,ZHU J,et al.Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release[J].Nanoscale,2020,12(4):2673-2685.
[59] LUO Q,LIN L,HUANG Q,et al.Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol)methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect[J].Acta Biomater,2022(143):320-332.
[60] LUO L,XU F S,PENG H L,et al.Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis[J].J Control Release,2020(318):124-135.
[61] 韩天娇,胡玉玺,付宏征.高分子前药的研究进展[J].中国药科大学学报,2019,50(4):397-404.
[62] ZHAO H B,YU J,ZHANG R S,et al.Doxorubicin prodrug-based nanomedicines for the treatment of cancer[J].Eur J Med Chem,2023(258):115612.
[63] RANI P,RAHIM J U,PATRA S,et al.Tumor microenvironment-responsive self-assembling polymeric prodrug-based nanomaterials for cancer therapy[J].J Drug Deliv Sci Technol,2024(96):105715.
[64] 王朝辉,刘玉玲.抗肿瘤纳米药物的临床转化进展及展望[J].药学学报,2022,57(1):134-141,277.
[65] 仲曼,胡慧慧,缪明星,等.纳米药物制剂体内分析方法及药动学研究进展和问题策略分析[J].药物评价研究,2022,45(7):1413-1425.
[66] YAO M N,MA X T,ZHANG X,et al.Lectin-mediated pH-sensitive doxorubicin prodrug for pre-targeted chemotherapy of colorectal cancer with enhanced efficacy and reduced side effects[J].Theranostics,2019,9(3):747-760.
[67] 李玲,汪哲,谭宁华.天然产物靶向肿瘤微环境的研究进展[J].药学学报,2021,56(6):1580-1590.